At first glance, Walgreens’ plan to partner with Uber and DoorDash to provide free delivery of Paxlovid (nirmatrelvir tablets; ritonavir tablets) for COVID-19 patients in underserved communities looks like a great plan that could be invaluable in warding off a winter surge. Look a bit deeper, though, and it’s unclear exactly how effective the plan will be. Most problematically, it presumes that those underserved communities have a Walgreens nearby and that the ride share and …
Read More